The observations warrant further investigation of salt-dependent autocrine/paracrine systems, such as PGE2-EP1, as therapeutic targets for hyperkalemia that accompanies low sodium-delivery states, like CKD and heart failure. Here, PTGER1 is linked to chronic kidney disease.